Brief: Venus Medtech Hangzhou Posts H1 Revenue RMB 230.7 Million
30/08/2024 14:06
Aug 30 (Reuters) - Venus Medtech Hangzhou H1 revenue RMB 230.7 million. * H1 capex RMB 46.2 million
Recent news on Venus Medtech (Hangzhou)
See all newsBrief: Venus Medtech Hangzhou To Issue 184.5 Million Shares And HK$379.7 Million Convertible Bonds
Brief: Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million
Brief: Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive Director
Brief: Venus Medtech Hangzhou Logs FY Revenue RMB 306.8 Mln
Brief: Venus Medtech Says Unaware Of Any Info Needing Disclosure To Avoid False Market